Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
53
ENVX Quote, Financials, Valuation and Earnings
Last price:
$15.93
Seasonality move
:
6.55%
Day range:
$14.04 - $15.35
52-week range:
$5.27 - $18.06
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
119.27x
P/B ratio:
12.33x
Volume:
11.9M
Avg. volume:
7.3M
1-year change:
-17.31%
Market cap:
$2.9B
Revenue:
$23.1M
EPS (TTM):
-$1.29
Analysts' Opinion
-
Consensus RatingEnovix has received a consensus rating of Buy. The company's average rating is a Buy based on 9 Buy ratings, 2 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $26.55, Enovix has an estimated upside of 75.8% from its current price of $15.10.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $9.00 representing 40.4% downside risk from its current price of $15.10.
Fair Value
-
According to the consensus of 11 analysts, Enovix has 75.8% upside to fair value with a price target of $26.55 per share.
ENVX vs. S&P 500
-
Over the past 5 trading days, Enovix has overperformed the S&P 500 by 9.99% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Enovix does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Enovix revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Enovix reported revenues of $5.1M.
Earnings Growth
-
Enovix has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Enovix reported earnings per share of -$0.12.
Enterprise value:
2.8B
EV / Invested capital:
--
Price / LTM sales:
119.27x
EV / EBIT:
--
EV / Revenue:
123.72x
PEG ratio (5yr expected):
-0.59x
EV / Free cash flow:
-17.95x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$16K
Return On Assets:
-40.33%
Net Income Margin (TTM):
-870.67%
Return On Equity:
-93.82%
Return On Invested Capital:
-50.92%
Operating Margin:
-834.84%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $6.2M | $12.9M | $22.9M | $5.3M | $5.1M | |
| Gross Profit | -$28.7M | -$45M | $16K | -$1.8M | $261K | |
| Operating Income | -$165.2M | -$229.7M | -$173.3M | -$70.1M | -$42.6M | |
| EBITDA | -$156.8M | -$126.3M | -$165.7M | -$20M | -$13.5M | |
| Diluted EPS | -$1.45 | -$1.34 | -$1.29 | -$0.28 | -$0.12 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | $415.5M | $301.2M | $278M | $270.2M | |
| Total Assets | -- | $506.3M | $410.6M | $508.9M | $499M | |
| Current Liabilities | -- | $17.5M | $25.1M | $56.9M | $57.8M | |
| Total Liabilities | -- | $85.2M | $98.5M | $276.8M | $261.3M | |
| Total Equity | -- | $421.1M | $312.1M | $232.1M | $237.8M | |
| Total Debt | -- | -- | -- | $176.8M | $179.6M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$88.7M | -$114.1M | -$90.5M | -$35M | -$16.9M | |
| Cash From Investing | -$28.8M | -$120.8M | -$84.9M | $19.1M | -$64.4M | |
| Cash From Financing | $3M | $165.5M | $143.8M | $5.4M | -$1.5M | |
| Free Cash Flow | -$117.5M | -$187.9M | -$157.9M | -$50.1M | -$23.2M | |
ENVX
Sector
Market Cap
$2.9B
$611.3M
Price % of 52-Week High
83.61%
81.21%
Dividend Yield
0%
0%
Shareholder Yield
-7.68%
2.28%
1-Year Price Total Return
-17.31%
-1.12%
Beta (5-Year)
--
0.761
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$14.10
200-day SMA
Buy
Level
$9.43
Bollinger Bands (100)
Buy
Level
6.26 - 10.52
Chaikin Money Flow
Sell
Level
-6M
20-day SMA
Buy
Level
$11.34
Relative Strength Index (RSI14)
Buy
Level
83.72
ADX Line
Buy
Level
34.49
Williams %R
Sell
Level
-15.1373
50-day SMA
Buy
Level
$9.21
MACD (12, 26)
Buy
Level
3.97
25-day Aroon Oscillator
Buy
Level
60
On Balance Volume
Neutral
Level
29.6M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.5276)
Sell
CA Score
(Annual)
Level (-2.4148)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (3)
Sell
Ohlson Score
Level (2.5703)
Buy
Piotroski F Score
(Annual)
Level (6)
Sell
Quality Ratio Score
Level (1)
Sell
Fundamental Score
Level (4)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Enovix Corp is engaged in designing, developing, manufacturing, and commercializing Lithium-ion, or Li-ion, battery cells. It uses BreakFlow and Encapsulation technologies to manufacture high capacity and resilient batteries. The company's product portfolio comprises power disc batteries, flexible lithium-ion polymer batteries, superior lithium-ion polymer batteries, active silicon lithium-ion cells, and others. Geographically, the company generates maximum revenue from its customers in South Korea, followed by Switzerland, Norway, the United States, Taiwan, and other regions.
Stock Forecast FAQ
In the current month, ENVX has received 9 Buy ratings 2 Hold ratings, and 0 Sell ratings. The ENVX average analyst price target in the past 3 months is $26.55.
-
Where Will Enovix Stock Be In 1 Year?
According to analysts, the consensus estimate is that Enovix share price will rise to $26.55 per share over the next 12 months.
-
What Do Analysts Say About Enovix?
Analysts are divided on their view about Enovix share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Enovix is a Sell and believe this share price will drop from its current level to $9.00.
-
What Is Enovix's Price Target?
The price target for Enovix over the next 1-year time period is forecast to be $26.55 according to 11 Wall Street analysts, 9 of them rate the stock a Buy, 0 rate the stock a Sell, and 2 analysts rate the stock a Hold.
-
Is ENVX A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Enovix is a Buy. 9 of 11 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of ENVX?
You can purchase shares of Enovix via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Enovix shares.
-
What Is The Enovix Share Price Today?
Enovix was last trading at $15.93 per share. This represents the most recent stock quote for Enovix. Yesterday, Enovix closed at $15.10 per share.
-
How To Buy Enovix Stock Online?
In order to purchase Enovix stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
